Cargando…

O2.3. ABNORMAL BRAIN AGING IN YOUTH WITH SUBCLINICAL PSYCHOSIS AND OBSESSIVE-COMPULSIVE SYMPTOMS

BACKGROUND: Psychiatric symptoms in childhood and adolescence have been associated with both delayed and accelerated patterns of grey matter development. This suggests that deviation in brain structure from a normative range of variation for a given age might be important in the emergence of psychop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cropley, Vanessa, Tian, Ye, Fernando, Kavisha, Mansour, Sina, Pantelis, Christos, Cocchi, Luca, Zalesky, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Oral Session: Digital Health/Methods
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233979/ http://dx.doi.org/10.1093/schbul/sbaa028.008

Ejemplares similares

O6.6. MULTIMODAL PROGNOSIS OF NEGATIVE SYMPTOM SEVERITY IN INDIVIDUALS WITH INCREASED RISK OF DEVELOPING PSYCHOSIS
por: Hauke, Daniel, et al.
Publicado: (2020)

O5.6. ADVANCED DIFFUSION IMAGING IN PSYCHOSIS RISK: A CROSS-SECTIONAL AND LONGITUDINAL STUDY OF WHITE MATTER DEVELOPMENT
por: Di Biase, Maria, et al.
Publicado: (2020)

O8.2. VALIDATION OF A COMPUTERIZED ADAPTIVE TESTING TOOL FOR PSYCHOSIS: THE CAT-PSYCHOSIS BATTERY
por: Guinart, Daniel, et al.
Publicado: (2020)

O2.5. CORTICAL PATTERNING OF ABNORMAL MORPHOMETRIC SIMILARITY IN PSYCHOSIS IS ASSOCIATED WITH BRAIN EXPRESSION OF SCHIZOPHRENIA-RELATED GENES
Publicado: (2020)

O6.4. ASSOCIATION BETWEEN CLUSTERS OF FORMAL THOUGHT DISORDERS SEVERITY AND NEUROCOGNITIVE AND FUNCTIONAL OUTCOME INDICES IN THE EARLY STAGES OF PSYCHOSIS – RESULTS FROM THE PRONIA COHORT
por: Öztürk, Ömer Faruk, et al.
Publicado: (2020)

O5.2. CBD MODULATION OF HIPPOCAMPAL GLUTAMATE IN PSYCHOSIS
por: O’Neill, Aisling, et al.
Publicado: (2020)

O5.4. THALAMIC CONNECTIVITY IN EARLY PSYCHOSIS DURING TASK AND AT REST
por: Berge, Daniel, et al.
Publicado: (2020)

O8.3. DEVELOPMENT AND UTILITY OF THE MAUDSLEY ENVIRONMENTAL RISK SCORE FOR PSYCHOSIS
Publicado: (2020)

O10.6. ANTERIOR VERSUS POSTERIOR HIPPOCAMPUS WITHIN PSYCHOSIS: A BSNIP STUDY
por: del Re, Elisabetta C, et al.
Publicado: (2020)

O1.2. REDUCING THE DURATION OF UNTREATED PSYCHOSIS IN A U.S. CATCHMENT: THE MINDMAP CAMPAIGN
por: Srihari, Vinod, et al.
Publicado: (2020)

O3.4. PSYCHOSIS PHENOTYPES FROM B-SNIP FOR CLINICAL ADVANCES: BIOTYPE CHARACTERISTICS AND TARGETS
por: Clementz, Brett, et al.
Publicado: (2020)

O10.4. THE ROLE OF CONTEXTUAL FACTORS AND ASSESSMENT STRATEGIES IN THE ACCURATE SCREENING OF PSYCHOSIS-RISK SYMPTOMS
por: Schiffman, Jason, et al.
Publicado: (2020)

O9.3. CANNABIS CONSUMPTION INCREASES RISK OF PSYCHOSIS IN A SUBGROUP OF PATIENTS WITH HIGH PERIPHERAL BLOOD INFLAMMATION
por: Corsi-Zuelli, Fabiana, et al.
Publicado: (2020)

O6.1. COGNITIVE CONTROL DIFFERENCES BETWEEN TREATMENT RESPONSIVE AND TREATMENT RESISTANT FIRST-EPISODE PSYCHOSIS PATIENTS
Publicado: (2020)

O5.3. IMPAIRED LEFT TEMPORAL-PARIETAL JUNCTION FMRI ACTIVITY DURING CATEGORY FLUENCY IN FIRST-EPISODE PSYCHOSIS
por: Perumaly, Leana, et al.
Publicado: (2020)

O3.5. EARLY TRAJECTORIES OF POSITIVE SYMPTOMS REMISSION IN FIRST EPISODE-PSYCHOSIS: A 2-YEAR FOLLOW-UP STUDY
por: Percie du Sert, Olivier, et al.
Publicado: (2020)

O6.3. ASSOCIATIONS BETWEEN COGNITIVE FUNCTION AND CORTICAL LEVELS OF GLUTAMATE AND GABA IN ANTIPSYCHOTIC-NAïVE PATIENTS WITH SCHIZOPHRENIA OR PSYCHOSIS
por: Bojesen, Kirsten, et al.
Publicado: (2020)

O10.2. DEFICIENT VISUAL ODDBALL STIMULUS PROCESSING PREDICTS PSYCHOSIS ONSET: RESULTS FROM THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY
por: Hamilton, Holly, et al.
Publicado: (2020)

O1.3. BACK TO THE FUTURE: PREDICTING POPULATION NEED FOR PSYCHOSIS CARE BASED ON THE EPIDEMIOLOGY OF PSYCHOTIC DISORDERS IN ENGLAND, AN APPLIED BAYESIAN METHODOLOGY
por: McDonald, Keltie, et al.
Publicado: (2020)

O10.5. CLINICAL HIGH RISK (CHR) CRITERIA IN CHILDREN AND ADOLESCENTS NOT SUSPECTED TO DEVELOP PSYCHOSIS: NO TRANSDIAGNOSTIC SEVERITY MARKER OF MENTAL HEALTH PROBLEMS
por: Schultze-Lutter, Frauke, et al.
Publicado: (2020)

O10.1. MATERNAL PRENATAL C-REACTIVE PROTEIN, NEURODEVELOPMENT AND OTHER RISK FACTORS FOR PSYCHOSIS IN ADOLESCENT OFFSPRING IN THE NORTHERN FINLAND BIRTH COHORT 1986
por: Ramsay, Hugh, et al.
Publicado: (2020)

O11.1. MULTIPLE GENOMIC MEASURES OF SCHIZOPHRENIA RISK ARE RELATED TO CORTICAL THICKNESS IN TYPICALLY DEVELOPING YOUTH AND YOUNG ADULTS
por: Jalbrzikowski, Maria, et al.
Publicado: (2020)

O4.5. LONG TERM EFFECTS OF EARLY INTERVENTION SERVICES FOR FIRST EPISODE PSYCHOSIS: OUTCOMES OVER FIVE YEARS FROM THE RECOVERY AFTER A 1ST EPISODE OF SCHIZOPHRENIA-EARLY TREATMENT PROGRAM (RAISE-ETP)
por: Robinson, Delbert, et al.
Publicado: (2020)

O8.5. SIGNS OF ADVERSITY - A NOVEL MACHINE LEARNING APPROACH TO CHILDHOOD TRAUMA, BRAIN STRUCTURE AND CLINICAL PROFILES
por: Popovic, David, et al.
Publicado: (2020)

Obsessive Compulsive Disorder Masquerading as Psychosis
por: Raveendranathan, Dhanya, et al.
Publicado: (2012)

Transcranial magnetic stimulation in obsessive-compulsive disorder: A focus on network mechanisms and state dependence
por: Cocchi, Luca, et al.
Publicado: (2018)

O2.6. DELUSIONS ASSOCIATED WITH ABNORMAL FRONTOSTRIATAL EFFECTIVE CONNECTIVITY IN A SPECTRAL DCM ANALYSIS OF RESTING STATE FMRI
por: Okuneye, Victoria, et al.
Publicado: (2020)

Psychosis or Obsessions? Clozapine Associated with Worsening Obsessive-Compulsive Symptoms
por: Leung, Jonathan G., et al.
Publicado: (2016)

Revisiting deficits in threat and safety appraisal in obsessive‐compulsive disorder
por: Hearne, Luke J., et al.
Publicado: (2023)

S187. EXPLORING NEURODEVELOPMENTAL AND FAMILIAL ORIGINS OF NEUROLOGICAL SOFT SIGNS IN SCHIZOPHRENIA
por: Cooper, Rebecca, et al.
Publicado: (2020)

The Cost of Obsessive–Compulsive Disorder in Swedish Youth
por: Lenhard, Fabian, et al.
Publicado: (2021)

O11.6. THE ROLE OF SERUM GLUTAMATE AND ASPARTATE AS MARKERS FOR CLOZAPINE RESPONSE AND IN THE MECHANISM OF ACTION – DATA FROM HUMAN AND ANIMAL MODEL STUDIES
Publicado: (2020)

O9.7. TECHNOLOGY ASSISTED RELAPSE PREVENTION PROGRAM REDUCES HOSPITALIZATION IN SCHIZOPHRENIA PATIENTS AT HIGH RISK FOR RELAPSE
por: Schooler, Nina, et al.
Publicado: (2020)

O9.4. RELATIONSHIPS BETWEEN AGE AT ONSET OF PSYCHOTIC SYMPTOMS AND POOR RESPONSE TO ANTIPSYCHOTICS IN A SAMPLE OF TRS/NON-TRS PATIENTS
por: Iasevoli, Felice, et al.
Publicado: (2020)

O1.4. HOW THE MOST CITED RESEARCH ARTICLES ABOUT SCHIZOPHRENIA IN 2018 DEPICT THE DISEASE?
por: Tonsig, Gabriela, et al.
Publicado: (2020)

O7.1. ASSOCIATION BETWEEN PATTERNS OF COMORBID MENTAL DISORDERS AND MORTALITY-RELATED ESTIMATES. A NATIONWIDE, REGISTER-BASED COHORT STUDY BASED ON 7.5 MILLION INDIVIDUALS LIVING IN DENMARK
por: Plana-Ripoll, Oleguer, et al.
Publicado: (2020)

O3.6. PREVALENCE OF AND RECOVERY FROM COMMON MENTAL DISORDERS INCLUDING PSYCHOTIC EXPERIENCES
por: Perez, Jesus, et al.
Publicado: (2020)

O7.5. STANDARDIZED MORTALITY RATIOS IN EARLY- AND ADULT ONSET FOR THREE DISORDERS
por: Lammers Vernal, Ditte, et al.
Publicado: (2020)

O2.2. EVALUATION OF THE RELATIONSHIP BETWEEN GLUTAMATE AND BRAIN CONNECTIVITY IN ANTIPSYCHOTIC-NAïVE FIRST EPISODE PATIENTS – A COMBINED MAGNETIC RESONANCE SPECTROSCOPY AND RESTING STATE FUNCTIONAL CONNECTIVITY MRI STUDY
por: Maximo, Jose, et al.
Publicado: (2020)

O7.3. EXPLORING COMORBIDITY BETWEEN MENTAL DISORDERS AND GENERAL MEDICAL CONDITIONS
por: Momen, Natalie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lmaqvg4ilkurbn3k9dmela3vbo